Apolipoprotein E—associated risk for Alzheimer's disease in the African‐American population is genotype dependent

Amrik Sahota, Min Yang, Sujuan Gao, Siu L. Hui, Olusegun Baiyewu, Oye Gureje, Steven Oluwole, Adesola Ogunniyi, Kathleen Hall, Hugh C. Hendrie

Annals of Neurology · 1997 · 84 citations · 12 references

Concepts

Abstract

As a part of our ongoing study on Alzheimer's disease (AD) in elderly African Americans, we obtained clinical assessment and apolipoprotein E (ApoE) genotype data on 288 individuals (including 60 with AD). The ApoE epsilon4 allele frequency was significantly increased in AD patients compared with controls. The age-adjusted odds ratio (OR) for AD in epsilon4 homozygotes was 4.83 (95% confidence interval [CI], 1.71-13.64) compared with the epsilon3/epsilon3 genotype, but the OR for AD with the epsilon3/epsilon4 genotype did not reach significance (1.20; 95% CI, 0.58-2.45). These findings suggest that the association between ApoE epsilon4 and AD is weaker in African Americans than in whites.

References

12